Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2026 Earnings Call Transcript

SA Transcripts 161.61K Followers Follow Amphastar Pharmaceuticals, Inc. ( AMPH ) Q2 2026 Earnings Call August 6, 2026 5:00 PM EDT Company Participants Dan Dischner - Senior Vice President of Human Resources & Corporate Communication William Peters - CFO, Executive VP of Finance, Treasurer & Director Tony Marrs - Executive VP of Regulatory Affairs & Clinical Operations Conference Call Participants Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Yuchen Ding - Jefferies LLC, Research Division Naoki Martin - Piper Sandler & Co., Research Division John Gionco - Needham & Company, LLC, Research Division Tianqi Hang - Wells Fargo Securities, LLC, Research Division Presentation Operator Greetingsn and welcome to the Amphastar Pharmaceuticals, Inc. Second Quarter Earnings Call. [Operator Instructions] Please note that certain statements made during this call regarding matters that are not historical facts, including but not limited to management's outlook or predictions for future periods, are forward-looking statements. These statements are based solely on information that is now available to us. We encourage you to review the section entitled Forward-Looking Statements in the press release issued today and the presentation on the company's website. Please refer to our SEC filings, which can be found on the company's website and the SEC's website, for a discussion of numerous factors that may impact our future performance. We will also discuss certain non-GAAP measures. Important information on our use of these measures and reconciliations to U.S. GAAP may be found in our earnings release. Please note this conference is being recorded. Our speakers today are Mr. Bill Peters, CFO; Mr. Dan Dischner, Senior Vice President of Corporate Communications; and Mr. Tony Marrs, Executive Vice President of Regulatory Affairs and Clinical Operations. I will now turn the conference over to your host, Mr. Dan Dischner, Senior Vice President of Corporate Communications. Dan, you may begin. Dan Dischner Senior Vice President of Human